LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

Search

Globus Medical Inc (Class A)

Закрыт

СекторЗдравоохранение

86.5 -2.37

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

85.8

Макс.

86.96

Ключевые показатели

By Trading Economics

Доход

-84M

119M

Продажи

24M

769M

P/E

Средняя по отрасли

28.803

77.671

Прибыль на акцию

1.18

Рентабельность продаж

15.469

Сотрудники

5,300

EBITDA

22M

215M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+11.19% upside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

3.8B

12B

Предыдущая цена открытия

88.87

Предыдущая цена закрытия

86.5

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Globus Medical Inc (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

13 дек. 2025 г., 00:04 UTC

Приобретения, слияния, поглощения

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

12 дек. 2025 г., 16:42 UTC

Приобретения, слияния, поглощения

FTC Sues to Block Henkel's $725 Million Deal for Liquid Nails From PE Firm -- 2nd Update

13 дек. 2025 г., 16:48 UTC

Приобретения, слияния, поглощения

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 дек. 2025 г., 08:00 UTC

Приобретения, слияния, поглощения

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 дек. 2025 г., 00:24 UTC

Приобретения, слияния, поглощения

Want a Piece Of SpaceX? -- Barrons.com

12 дек. 2025 г., 23:49 UTC

Приобретения, слияния, поглощения

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 дек. 2025 г., 22:52 UTC

Обсуждения рынка

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 дек. 2025 г., 22:32 UTC

Отчет

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 дек. 2025 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

12 дек. 2025 г., 20:45 UTC

Отчет

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 дек. 2025 г., 20:41 UTC

Обсуждения рынка

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 дек. 2025 г., 20:20 UTC

Обсуждения рынка

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 дек. 2025 г., 19:23 UTC

Отчет

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 дек. 2025 г., 18:35 UTC

Приобретения, слияния, поглощения

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 дек. 2025 г., 18:33 UTC

Приобретения, слияния, поглощения

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 дек. 2025 г., 18:31 UTC

Обсуждения рынка

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 дек. 2025 г., 17:49 UTC

Отчет

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 дек. 2025 г., 17:34 UTC

Приобретения, слияния, поглощения

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

12 дек. 2025 г., 17:33 UTC

Приобретения, слияния, поглощения

Orange: Closing of the Transaction Is Expected in the First Half of 2026

12 дек. 2025 г., 17:33 UTC

Приобретения, слияния, поглощения

Orange: Agreement Confirms the Non-Binding Agreement That Was Previously Announced Oct. 31

12 дек. 2025 г., 17:32 UTC

Приобретения, слияния, поглощения

Orange: MasOrange Is Spain's Leading Operator in Terms of Customer Base

12 дек. 2025 г., 17:31 UTC

Приобретения, слияния, поглощения

Orange to Buy the Stake for EU4.25B in Cash

12 дек. 2025 г., 17:24 UTC

Обсуждения рынка

Argentina Predicts Record Wheat Crop -- Market Talk

12 дек. 2025 г., 17:20 UTC

Обсуждения рынка
Отчет

Tech, Media & Telecom Roundup: Market Talk

12 дек. 2025 г., 17:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

12 дек. 2025 г., 17:18 UTC

Обсуждения рынка
Отчет

Broadcom, Oracle Investor Reactions Show High Bar for AI Cos. -- Market Talk

12 дек. 2025 г., 17:09 UTC

Обсуждения рынка

Broadcom Investors Were Primed to Sell Shares -- Market Talk

12 дек. 2025 г., 17:09 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

12 дек. 2025 г., 16:47 UTC

Обсуждения рынка

Broadcom's Margins Expected to Narrow Due to AI Revenue -- Market Talk

12 дек. 2025 г., 16:39 UTC

Обсуждения рынка

Supply Limits, Geopolitical Risk to Support Crude in 2026 -- Market Talk

Сравнение c конкурентами

Изменение цены

Globus Medical Inc (Class A) Прогноз

Целевая цена

By TipRanks

11.19% рост

Прогноз на 12 месяцев

Средняя 96.4 USD  11.19%

Максимум 114 USD

Минимум 64 USD

Основано на мнении 12 аналитиков Wall Street, спрогнозировавших целевые цены для Globus Medical Inc (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

12 ratings

9

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

72.18 / 73.07Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat